Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations
Year: 2018
Type: review
Source: Clinical Infectious Diseases
DOI: 10.1093/cid/ciy576
Authors: Jason M Pogue, Robert A Bonomo, Keith S Kaye
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2883732289
